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Generation of transgenic 
cynomolgus monkeys that 
express green fluorescent protein 
throughout the whole body
Yasunari Seita1,2, Tomoyuki Tsukiyama1, Chizuru Iwatani1,2, Hideaki Tsuchiya1, 
Jun Matsushita1,2, Takuya Azami3, Junko Okahara4, Shinichiro Nakamura1, 
Yoshitaka Hayashi5, Seiji Hitoshi5, Yasushi Itoh6, Takeshi Imamura7, Masaki Nishimura8, 
Ikuo Tooyama8, Hiroyuki Miyoshi9, Mitinori Saitou2,10,11,12, Kazumasa Ogasawara6, 
Erika Sasaki4 & Masatsugu Ema1,13
Nonhuman primates are valuable for human disease modelling, because rodents poorly recapitulate 
some human diseases such as Parkinson’s disease and Alzheimer’s disease amongst others. Here, we 
report for the first time, the generation of green fluorescent protein (GFP) transgenic cynomolgus 
monkeys by lentivirus infection. Our data show that the use of a human cytomegalovirus immediate-
early enhancer and chicken beta actin promoter (CAG) directed the ubiquitous expression of the 
transgene in cynomolgus monkeys. We also found that injection into mature oocytes before fertilization 
achieved homogenous expression of GFP in each tissue, including the amnion, and fibroblasts, 
whereas injection into fertilized oocytes generated a transgenic cynomolgus monkey with mosaic GFP 
expression. Thus, the injection timing was important to create transgenic cynomolgus monkeys that 
expressed GFP homogenously in each of the various tissues. The strategy established in this work will 
be useful for the generation of transgenic cynomolgus monkeys for transplantation studies as well as 
biomedical research.
To date, many transgenic animals have been developed including mice1,2, rats3,4 and domestic animals5. Although 
many human disease models have used these transgenic animals, most used mice because the technique of genetic 
manipulation, such as generation of transgenic animals by DNA microinjection into pronuclear embryos2,6,7 
and generation of gene-targeting animals by using homologous recombination in embryonic stem cells8,9, have 
been established. While rodents are valuable models for biomedical research, the evolutionary distance between 
rodents and humans is almost 87 million years10, and rodents do not always recapitulate human behavioural and 
biological responses11. For example, it is difficult to use mice as models for AIDS10, because the host range for 
1Department of Stem Cells and Human Disease Models, Research Center for Animal Life Science, Shiga University 
of Medical Science, Seta, Tsukinowa-cho, Otsu, Shiga 520-2192, Japan. 2JST, ERATO, Yoshida-Konoe-cho, 
Sakyo-ku, Kyoto 606-8501, Japan. 3Department of Anatomy and Embryology, Faculty of Medicine, University of 
Tsukuba, Tennodai 1-1-1, Tsukuba, Ibaraki 305-8577, Japan. 4Central Institute for Experimental Animals, 1430 
Nogawa, Miyamae-ku, Kawasaki, Kanagawa 216-0001, Japan. 5Department of Physiology, Shiga University of 
Medical Science, Otsu, Shiga 520-2192, Japan. 6Department of Pathology, Shiga University of Medical Science, 
Otsu, Shiga 520-2192, Japan. 7Department of Pharmacology, Shiga University of Medical Science, Otsu, Shiga 
520-2192, Japan. 8Molecular Neuroscience Research Center, Shiga University of Medical Science, Otsu, Japan. 
9Department of Physiology, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, 
Japan. 10Department of Anatomy and Cell Biology, Graduate School of Medicine, Kyoto University, Yoshida-Konoe-
cho, Sakyo-ku, Kyoto 606-8501, Japan. 11Department of Reprogramming Science, Center for iPS Cell Research and 
Application, Kyoto University, 53 Kawahara-cho, Shogoin Yoshida, Sakyo-ku, Kyoto 606-8507, Japan. 12Institute for 
Integrated Cell-Material Sciences, Kyoto University, Yoshida-Ushinomiya-cho, Sakyo-ku, Kyoto 606-8501, Japan. 
13PRESTO, Japan Science and Technology Agency (JST), 4-1-8 Honcho Kawaguchi, Saitama 332-0012, Japan. 
Correspondence and requests for materials should be addressed to M.E. (email: mema@belle.shiga-med.ac.jp)
Received: 30 January 2016
Accepted: 06 April 2016
Published: 25 April 2016
OPEN
www.nature.com/scientificreports/
2Scientific RepoRts | 6:24868 | DOI: 10.1038/srep24868
human immunodeficiency virus is highly restricted; for influenza11 because the pathogenesis in mice is different 
from that in humans and influenza virus causes hypothermia12 and severe viral pneumonia13,14; and for lung 
disorders15 such as asthma, because the original findings of asthma obtained from mouse models had limited 
success in humans studies16. Additionally, the pathological and behavioural phenotypes of mouse genetic models 
are often quite different from the human condition. The inactivation of Parkinson’s disease (PD) genes Pink117, 
Parkin18, Dj-119, Lrrk220 was insufficient to cause PD in mice. Triple knockout mice lacking Parkin, DJ-1, and 
Pink1 have normal morphology, and normal numbers of dopaminergic and noradrenergic neurons in the sub-
stantia nigra21. Mouse knockout models of human tumour suppressor genes also often display a tumour spectrum 
at variance with the human pathology. For example, in humans, germline or somatic RB gene loss is associated 
with the development of retinoblastomas and osteosarcomas and, later in life, with small cell lung carcinomas, 
whereas mice with an Rb deletion fail to develop these types of tumours22. Accordingly, it is required to establish 
transgenic animal models to recapitulate human diseases.
Nonhuman primates (NHPs) are considered one of the most valuable animal models. Several NHPs are used 
as laboratory animals, including New World monkeys such as common marmosets, and Old World monkeys such 
as rhesus monkeys and cynomolgus monkeys. Common marmosets clearly exhibit anthropoid primate character-
istics, are relatively inexpensive to maintain, mature by 1.5–2 years of age, produce next generation offspring by 3 
years of age and give birth to 3–5 offspring per year23. However, marmosets exhibit physiological and functional 
differences relative to humans to a greater degree than do Old World primates. These differences include pituitary 
gonadotropin secretion and action24, their ability to maintain bone mass without the need for gonadal estrogen25, 
lack of age-related ovulation decline26 and high fasting glucose and triglyceride levels27. In contrast, Old World 
monkeys are closer to humans in organ size and structure and therefore have been used for disease models such 
as stroke28,29, Parkinson’s disease30,31, Huntington’s disease32,33 and transplantation studies34,35. Especially, cyno-
molgus monkeys are considered a useful animal model because they can be bred throughout the year in contrast 
to rhesus macaques that have seasonal breeding pattern.
Green fluorescent protein (GFP) is frequently used in biomedical research and GFP-expressing animals are 
an important source of bone marrow, spermatogonial stem cells and organ transplantation, and pre-implantation 
embryos used to produce chimeric embryos. After the first transgenic NHPs were created by the transduction of 
GFP retroviral vector in 200136, a transgenic NHP model of Huntington’s disease was developed37. In 2009, the 
first transgenic NHPs with germline transmission were reported38. Recently, genome editing in monkeys using 
the CRISPR/Cas9 system39 and TALEN system40 was developed and used to generate human disease models41. 
Currently, GFP mice42, rats43, rabbits44,45, cats46, pig47, cattle48, common marmosets38 and rhesus monkeys36,37,49 
have been produced, yet no GFP cynomolgus monkey has been generated.
We report here for the first time, the generation of a GFP-expressing cynomolgus monkey. Our data show 
that the use of a human cytomegalovirus immediate-early enhancer and chicken beta actin promoter (CAG) 
directed the ubiquitous expression of the transgene in cynomolgus monkeys. Furthermore, we show that lenti-
viral injection into mature oocytes before fertilization is an efficient way to create transgenic NHPs with homog-
enous expression of GFP in each tissue, including the amnion, and fibroblasts. We also clearly demonstrate the 
fluorescence in the transgenic foetus was due to GFP expression and not autofluorescence, by using wild type 
tissues as negative controls. This system will contribute to creating human disease models and is also a good tool 
for transplantation studies.
Result
Production of GFP transgenic cynomolgus monkeys. In rodents, the pronuclear injection of DNA 
into fertilized eggs is an efficient strategy to generate transgenic animals. An alternative method is the use of 
genetically engineered embryonic stem cells. However, these strategies have been unsuccessful in NHPs to date. 
Since a transgenic marmoset with the capability of germ line transmission has been generated by injecting len-
tivirus into the perivitelline space of a two-cell-stage embryo38, we followed the technique to create a transgenic 
cynomolgus monkey.
Firstly, we constructed a lentiviral vector that carries GFP cDNA under the control of human cytomegalovirus 
early enhancer and chicken beta actin (CAG) promoter (Fig. 1A), because CAG promoter is able to achieve ubiq-
uitous expressions in various species50. Transfer of five lentivirus-injected embryos into three recipients resulted 
in two pregnancies, one of which ended in a miscarriage of twins on day 92 of gestation (Table 1). Detailed 
organ examination and histology identified no abnormalities (data not shown). Although one of the twins (#1) 
showed no detectable fluorescence, the other (#2) showed strong fluorescence in the face, skin, placenta and brain 
(Fig. 1B, data not shown). Strong fluorescence was observed in the organs of #2 foetus including the umbilical 
cord, placenta and amnion compared with #1 foetus under a fluorescent stereomicroscope (Fig. 1C). PCR analysis 
was performed to detect GFP transgene and demonstrated that the GFP transgene was integrated ubiquitously in 
the genome of all tissues in #2 foetus, but not #1 foetus. Consistent with this, RT-PCR analysis indicated that GFP 
mRNA was expressed ubiquitously in #2 foetus, but not #1 foetus (Fig. 1D). From these results, the #1 and #2 foe-
tuses were determined to be wild type (WT) and transgenic (Tg), respectively. Abundant GFP mRNA expression 
was detected in the brain, heart and pancreas in #2 foetus, while moderate GFP expression was detected in the 
kidney, spleen and amnion by RT-quantitative PCR (RT-qPCR) (Fig. 1E). We confirmed GFP protein expression 
in these organs by immunohistochemistry with an anti-GFP antibody and found that fluorescence was detected 
in all these organs from the #2 foetus (Fig. 2A). Strong fluorescence was observed in the heart, lung, spleen 
and stomach from #2 foetus, but not #1 foetus or the miscarried WT foetus (Fig. 2A, Supplementary Fig. 1A), 
under the same instrumental settings (same laser intensity, please see Materials and Methods). However, we 
detected moderate fluorescence in the liver and kidney in #1 foetus that was WT as indicated by PCR analysis 
(Fig. 2A). To investigate carefully the nature of the fluorescence, we examined tissues from the liver and kidney of 
another miscarried WT foetus and found that these organs also had comparable fluorescence (Fig. 2A). Careful 
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comparison revealed significant differences in the intensity and pattern of fluorescence between WT and #2 
foetus, demonstrating that the fluorescence observed in the tissues of #1 and WT foetuses were autofluores-
cence and that the fluorescence in the #2 foetus was derived from GFP protein. Regarding autofluorescence, as 
laser power increased, autofluorescence of hepatocytes in the liver and renal tubules in the kidney also increased 
(Supplementary Fig. 1B). WT monkey face exhibited moderate autofluorescence as if it is GFP transgenic monkey 
(Supplementary Fig. 1C), showing the importance of negative control. Taken together, we concluded that it was 
very important to compare fluorescence of WT and Tg at the same time, and #2 foetus was Tg with ubiquitous 
overexpression of the GFP protein.
Figure 1. GFP expression of day 92 aborted twin foetus. (A) Schematic representation of the lentiviral vector 
used for the transduction of GFP. LTR: long terminal repeat. CMV IE: human cytomegalovirus immediate 
early enhancer. WPRE: woodchuck hepatitis posttranscriptional regulatory element. (B) Epifluorescence 
images of the whole body and brain in day 92 aborted twin foetuses (#1 and #2). Inset in each panel shows 
bright images. (C) Epifluorescence in umbilical cords, placenta and amnion in day 92 aborted twin (#1 and #2) 
foetuses. Each organ on the left was obtained from #1 foetus, whereas those on the right were from #2 foetus. 
Strong epifluorescence was observed under excitation light (489 nm). (Scale bar: 500 μ m) (D). Genomic PCR 
(top panel) and RT-PCR (bottom panel) from #1 and #2 foetus organs. (E) GFP expression in #2 foetus organs 
evaluated by RT-qPCR. Data are represented as mean ± SD.
Injection timing of virus 24 h post ICSI
No. of embryos used 18
No. of 2 cell stage 18
No. of blastocyst (% per 2 cell) 5 (27.8)
ETs 5
No. of surrogates 3
No. of pregnancies at 30 days after ICSI 2
Multiple pregnancy 1 (twin)
Aborted 2*
Live birth 0
Table 1.  In vitro and in vivo development of cynomolgus monkey embryo after lentivirus injection.  
ET: embryo transfer. *One of the aborted foetus at 35 days after ICSI that was only placenta and the other foetus 
at 92 days after ICSI that was twin.
www.nature.com/scientificreports/
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Figure 2. GFP protein expression in various tissues. (A) Immunohistochemistry of tissues from a day 92 
aborted twin foetus detected by confocal microscopy. Note that #2 foetus shows overall strong GFP fluorescence 
in all the tissues examined, and that the WT liver and kidney showed moderate fluorescence (autofluorescence). 
Images were taken under the same instrumental settings (same laser intensity, etc). (Scale bar: 250 μ m) (B). 
Immunohistochemical analysis of #2 brain with anti-GFP, anti-GFAP and anti-NeuN antibodies. Colocalisation 
of GFP and NeuN or GFAP are shown by white arrows. (Scale bar: 10 μ m) (C). Immunohistochemical staining 
of #2 ovary with anti-OCT4 and VASA antibodies. Colocalisation of GFP and OCT4 or VASA are shown by 
white arrows. (Scale bar: 10 μ m).
www.nature.com/scientificreports/
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GFP expression in the brain tissue. To investigate the detailed expression of GFP in the brain of a day 
92 foetus, we examined the colocalisation of GFP, a radial glial and astroglial marker, glial fibrillary acidic pro-
tein (GFAP), and a neuronal specific nuclear protein marker, NeuN (Fig. 2B). Widespread GFP expression was 
observed throughout the cortex, including the forebrain, midbrain, and hindbrain. At a higher magnification, 
neuronal GFP expression was identified by its colocalisation with NeuN in the prefrontal cortex (Fig. 2B). GFP 
and GFAP were also colocalised in the lateral ventricle (Fig. 2B).
Germline transmission of the transgene. To investigate whether the transgene was transmitted to the 
germline, we examined the colocalisation of GFP and VASA (DDX4), a marker for primordial germ cell (PGC) 
of the ovary in the day 92 foetus. GFP and VASA were clearly colocalised in a subset of the ovary cells (Fig. 2C). 
Expression of OCT4, another marker for PGC was also well overlapped with that of GFP (Fig. 2C).
Partial GFP expression in the peripheral blood and fibroblasts. Previously, GFP transgenic mar-
moset showed partial GFP expression ranging from 0 to 19.1% in the whole peripheral blood38. To estimate the 
percentage of GFP positive cells in the peripheral blood of #2 foetus, immunohistochemistry with an anti-CD45 
antibody, a marker for white blood cells, was performed on the spleen and showed that 55% of CD45 positive cells 
expressed GFP protein (Fig. 3A), indicating that peripheral blood cells only partially expressed GFP.
To characterize GFP positive and negative cells, we established fibroblasts from the #2 foetus tail and 
found that about 60% of the cells were GFP-positive by FACS analysis (Fig. 3B,C). Interestingly, we found that 
GFP-negative cells also carried GFP transgene, suggesting that the transgene was not transcribed (Fig. 3C). 
Previous studies indicated that lentiviral transgene often undergo silencing through CpG methylation, and that 
treatment with valproic acid, a histone deacetylase inhibitor, was effective to rescue silenced gene transcrip-
tion51. When GFP-negative fibroblasts were cultured in the presence of valproic acid, a significant number of 
GFP-positive cells were observed, indicating that GFP silencing may be caused by histone deacetylation (Fig. 3D). 
Taken together, a GFP cynomolgus monkey foetus was successfully obtained, yet it only showed partial GFP 
expression and silencing of the transgene.
Optimization of lentivirus infection on GFP expression. To generate a transgenic cynomolgus mon-
key that expressed GFP homogenously in each of the various tissues, we optimized the lentivirus injection proto-
col. Since the lentivirus solution had a carryover of GFP protein contaminated in the process of virus production 
(Fig. 4A), we purified the lentivirus solution further by centrifugation in a sucrose cushion to remove GFP protein 
and obtained the highly purified lentiviral solution (Fig. 4A).
Wongsrikeao et al., reported that when virus was injected into mature oocytes before fertilization, uniform 
infection was achieved in a cat embryo46. Therefore, matured oocytes were subjected to perivitelline-space injec-
tion with lentivirus 4 h before intracytoplasmic sperm injection (ICSI) (PreI) (Fig. 4B). After the injection, the 
oocytes were cultured for 4 h and subjected to ICSI and cultured until blastocyst stage (day 8).
Full-term development of GFP cynomolgus monkeys. An offspring (named PreI Tg #1) from the 
PreI embryo was born successfully and showed strong fluorescence in the face and placenta compared with that 
of WT offspring (Fig. 4C,D). Amnion of PreI Tg #1 monkey showed homogenous GFP expression at the cellular 
level (Fig. 4E). PCR analysis was performed to detect GFP transgene and demonstrated that the GFP transgene 
was integrated in the genomic DNA from umbilical cord and placenta (Fig. 4F), demonstrating that PreI Tg #1 
monkey is a GFP transgenic.
Although PreI Tg #1 monkey clearly showed strong GFP fluorescence in the skin and homogenous GFP 
expression in the amnion at the cellular level, GFP expressions in the tissues were not addressed due to consid-
eration for animal welfare. Another offspring (named PreI Tg #2) was born, but died 3 days after birth (Table 2). 
Hypoplasia of the pituitary grand and pancreas were observed at the necropsy (data not shown). The whole 
body of the transgenic cynomolgus monkey showed strong fluorescence under an excitation light (Fig. 5A). The 
fluorescence was also detected in the placenta (Fig. 5A). PCR analysis indicated that GFP lentiviral transgene 
was integrated into the genome of various tissues (Fig. 5B). RT-PCR analysis indicated that GFP was expressed 
abundantly at the mRNA level in the brain, lung, kidney and stomach, while moderate GFP expression was 
observed in the heart, liver, pancreas, spleen, intestine and testis (Fig. 5B,C). Immunohistochemistry revealed 
abundant GFP expression in all tissues tested including the heart, lung, liver, kidney, spleen, stomach, and intes-
tine (Fig. 6A, Supplementary Fig. 2A,B). This was in sharp contrast with the autofluorescence observed in WT 
tissues (Fig. 6A). GFP protein expressions were also evident in lateral ventricle and grey matter layer (Fig. 6B). 
To investigate the contribution of the transgene to the germ cell lineage, we examined GFP expression in PGCs 
and found that almost all VASA-positive PGCs expressed GFP (Fig. 6C). To examine the ratio of GFP positive 
cells in offspring, high magnification images of sections were analysed and showed that > 95% of cells were GFP 
positive (data not shown). Furthermore, CD45 positive peripheral blood was analysed and 99% of CD45 positive 
cells expressed GFP (Fig. 6D). To demonstrate this more clearly, fibroblasts were established from the tail and 
ear of offspring, and almost all cells were GFP-positive under microscopic observation (Fig. 6E). Consistent with 
this, FACS analysis of fibroblasts showed that nearly 100% of cells were GFP-positive (Fig. 6E). Collectively, these 
results demonstrated that the GFP cynomolgus monkey created by PreI technique expressed GFP homogenously 
in each of the various tissues.
Comparison of expression levels of GFP protein in tissues from Tg monkeys and the GFP 
mouse. The green mice that ubiquitously express GFP have been created and been used for many biomedical 
researches such as transplantation studies52. Although the generation of GFP rhesus monkey and GFP marmoset 
have been reported36–38,49 previously, there was no study about the comparison of the level of GFP expression 
with that of the GFP mice. To evaluate the usefulness of GFP cynomolgus monkey established in this study, 
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Figure 3. Partial GFP expression in day 92 aborted twin foetuses. (A) Immunohistochemistry of spleen 
with anti-CD45 and GFP antibodies. A subset of CD45-positive white blood cells expressed GFP protein. 
Colocalisation of GFP and CD45 is shown by white arrows. (Scale bar: 25 μ m) (B). Fluorescent image of #2 tail 
fibroblasts. (Scale bar: 200 μ m) (C). Sorting of #2 tail fibroblasts by GFP intensity (upper left panel). Genomic 
PCR results from #2-① , #2-② and #2-③ tail fibroblasts (lower left panel). GFP expression in #2 foetus fibroblasts 
evaluated by RT-qPCR (right panel). Data are represented as mean ± SD. (D). Effect of sodium valproate (VPA) 
on GFP expression in GFP-negative (#2-① ) fibroblasts. GFP-expressing fibroblasts are indicated by white 
arrows. (Scale bar: 300 μ m).
www.nature.com/scientificreports/
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we compared GFP expression levels in tissues from GFP cynomolgus monkey with those from GFP mice42 by 
western blot analysis. Strong GFP expressions were detected in lung, kidney and spleen of PreI Tg cynomolgus 
Figure 4. Optimization of lentivirus injection for homogenous expression of GFP in each tissue.  
(A) Fluorescent images of a virus droplet after centrifugation without (− ) or with (+ ) a sucrose cushion. 
(Scale bar: 500 μ m) (B). Optimized transgenesis protocol. PreI: Pre-ICSI. PostI: Post-ICSI. (C). Epifluorescence 
image of the face in postnatal day 2 PreI Tg #1 offspring. Inset shows a bright image of PreI Tg #1 offspring and 
postnatal day 1 WT offspring. (D) Epifluorescence images of foetus side of placenta from PreI Tg #1 offspring 
and a part of WT placenta. Insets show bright images. (E) Fluorescence images of amnion from PreI Tg #1 
offspring and WT offspring. Nuclei were stained with Hoechst 33342. (Scale bar: 100 μ m) (F). Genomic PCR 
analysis with DNAs of organs from PreI Tg #1 offspring and WT offspring.
Group PreI Control
Injection timing of virus 4 h pre ICSI –
No. of embryos used 69 34
No. of 2 cell stage 56 18
No. of blastocyst (% per 2 cell) 25 (44.6) 10 (55.6)
ETs 17 –
No. of surrogates 17 –
No. of pregnancies at 30 days after ICSI 5 –
Spontaneous miscarriage 3 –
Live birth 2* –
Table 2. In vitro and in vivo development of PreI embryo. PreI: Pre-ICSI. ET: embryo transfer. *One offspring 
died three days after birth.
www.nature.com/scientificreports/
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Figure 5. GFP expression in transgenic cynomolgus monkey offspring at postnatal day 3. (A) Whole body 
and placenta epifluorescence imaging of Pre-ICSI transgenic (PreI Tg #2) offspring. Inset shows a bright image 
of 3 month old WT and PreI Tg #2 offspring. (Scale bar: 5 μ m) (B). Genomic PCR (upper panel) and RT-PCR 
(lower panel) results from PreI Tg #2 organs. (C). GFP expression of PreI Tg #2 organs evaluated by RT-qPCR. 
Data are represented as mean ± SD.
www.nature.com/scientificreports/
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monkey compared to those of GFP mouse (Fig. 7). #2 (Tg) foetus also expressed moderate level of GFP protein 
(Fig. 7). Thus, GFP cynomolgus monkeys generated in this study expressed even higher level of GFP protein in 
various tissues compared with those of GFP mice, and the technique established in this study will be very useful 
for the creation of human disease models.
Discussion
Transgenic NHPs will be valuable for human disease models, such as Parkinson’s disease and Alzheimer diseases. 
So far, transgenic NHP models of Huntington’s disease37 and Parkinson’s disease53 have been created and reported. 
GFP is frequently used in biomedical research and GFP-expressing animals are an important source of transplan-
tation studies. Previously, generation of GFP rhesus monkeys and GFP marmosets have been reported36–38,49, yet 
no GFP cynomolgus monkeys. To the best of our knowledge, this is the first study reporting the generation of 
GFP expressing cynomolgus monkeys. The strategy established in this study will be valuable for generating cyno-
molgus monkeys that homogenously overexpress a causative gene for human disease in each tissue.
Figure 6. Whole body analyses of PreI Tg #2 offspring. (A) Expression of GFP protein revealed by 
immunohistochemistry with anti-GFP antibodies of PreI Tg #2 offspring by confocal microscopy. Upper and 
lower panel show WT and PreI Tg #2 tissues, respectively. Images were taken under the same instrumental 
settings (same laser intensity, etc). (Scale bar: 100 μ m) (B). Immunohistochemical analysis of PreI Tg #2  
brain with anti-GFP antibodies. Inset a: white arrows show astrocyte and GFP colocalisation. Inset b: white 
arrows show neuron nuclei and GFP colocalisation. (Scale bar: upper panel 100 μ m, lower panel 25 μ m)  
(C). Immunohistochemical staining of PreI Tg #2 testis with anti-VASA antibodies. Colocalisation of GFP and 
VASA is shown by white arrows. (Scale bar: upper panel 50 μ m, lower panel 25 μ m) (D). Immunohistochemistry 
of PreI Tg #2 spleen with anti-CD45 and GFP antibodies. Homogenous GFP protein expression in CD45-
positive white blood cells was observed. Colocalisation of GFP and CD45 are shown by white arrows. (Scale bar: 
25 μ m) (E). Merged (Epifluorescence and Bright) images of fibroblasts from WT tail and PreI Tg #2 tail and ear. 
FACS analysis using fibroblasts from WT tail and PreI Tg #2 tail and ear. (Scale bar: 100 μ m).
www.nature.com/scientificreports/
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During the generation of GFP cynomolgus monkeys, we were aware that moderate fluorescence expression is 
detectable even in WT tissues. It was critically important to use WT tissues as a negative control to confirm the 
fluorescence derived from GFP protein in transgenic tissues. It is important to note that some previous reports of 
GFP transgenic monkeys showed only GFP transgenic tissues but not corresponding WT tissues36,37,49.
Our analysis indicated that when lentivirus was injected into a two-cell-stage embryo, partial GFP expression 
was achieved. Although lentivirus can transduce non-dividing cells, integration is significantly slowed by the 
nuclear membrane48,54. This has previously been observed in other species including marmosets38.This mosaicism 
may be caused by the delay of lentiviral integration into the genome. Interestingly, a bovine study showed that the 
lentiviral genome could not efficiently enter the pronucleus48. Wongsrikeao et al. examined the effect of infection 
timing and found mosaic expression was able to be avoided by injecting lentivirus into cat oocytes before IVF46. 
Consistent with this, when lentivirus was injected into cynomolgus monkey oocytes before fertilization, rather 
than the two-cell embryo stage, we obtained offspring with homogenous GFP expression in each tissue, showing 
that lentiviral injection into mature oocytes before fertilization is an effective way to create transgenic NHPs with 
homogenous expression of GFP in each of the various tissues, including the amnion, and fibroblasts.
NHPs are invaluable models for high order brain research into disorders such as Parkinson’s disease, Autism 
and Alzheimer’s disease. Alzheimer pathology is correlated strongly with the density of activated astrocytes55. In 
these cells, the expression of GFAP is strongly upregulated56,57. In Parkinson’s disease patients, the phosphoryla-
tion level of GFAP at serine 13 was significantly lower compared with control subjects58. As the present study indi-
cated that the GFP was expressed ubiquitously in various organs and cells including neuronal cells of transgenic 
cynomolgus monkeys, this transgenic technique will be useful to create human disease models for Parkinson’s 
disease and Alzheimer’s disease amongst others. The GFP cynomolgus monkey will also provide a source of green 
pre-implantation stage embryos, which can be used for the production of chimeric cynomolgus monkeys by the 
injection or aggregation with non-green embryonic stem cells.
Materials and Methods
Animals. Experimental procedures were approved by the Animal Care and Use Committee of Shiga University of 
Medical Science and methods were carried out in accordance with the approved guideline (Approval number: 26–42). 
Oocytes were collected from seven sexually mature female cynomolgus monkeys, aged 4–8 years and weighing 2.1–
3.9 kg. Twenty sexually mature females aged 4 years old and weighing 2.0–3.8 kg, were used as recipients. Sperm were 
collected from one sexually mature male cynomolgus monkey, aged 12 years and weighing 6.2 kg. Temperature and 
humidity in the animal rooms were maintained at 25 ± 2 °C and 50 ± 5%, respectively. Monkeys were housed indi-
vidually in cages (800 × 500 × 800 mm). The light cycle was 12 h of artificial light from 8 am. to 8 pm., Each animal 
was fed 20 g/kg of body weight of commercial pellet monkey chow (CMK-1; CLEA Japan, Inc., Tokyo, Japan) in the 
morning, supplemented with 20–50 g of sweet potato in the afternoon. Water was available ad libitum.
Oocyte collection. Ovarian stimulation and oocyte collection were carried out as previously described by 
Yamasaki et al.59 with some modifications. In brief, beginning at menses, the level of sex steroid hormones was 
reduced by subcutaneous injection of 0.9 mg of a gonadotropin-releasing hormone antagonist (Leuplin; Takeda 
Chemical Industries, Ltd., Osaka, Japan). Two weeks later, Micro infusion pump (iPRECIO SMP-200, ALZET 
Osmotic Pumps Co., Cupertino, CA, USA) with 15 IU/kg human follicle-stimulating hormone (hFSH; Asuka 
Pharmaceutical Co., Tokyo, Japan) was embedded subcutaneously under anesthesia and injected 7 μ l/h for 10 days. 
On the day after the last hFSH injection, 400 IU/kg human chorionic gonadotropin (hCG; Puberogen, Nippon 
Zenyaku Kogyo Co., Ltd., Fukushima, Japan) was injected intramuscularly. Oocytes were collected by follicular 
aspiration 40 h after hCG treatment, using a laparoscope (LA-6500, Machida Endoscope Co., Ltd., Chiba, Japan). 
Cumulus-oocyte complexes were recovered in Alpha modification of Eagle’s medium (MP Biomedicals LLC, Solon, 
OH, USA), containing 10% Serum Substitute Supplement (SSS; Irvine Scientific, Santa Ana, CA, USA) at 38 °C, in an 
atmosphere of humidified 5% CO2 and 95% in air for 1–2 h. Oocytes were stripped off cumulus cells by mechanical 
pipetting after brief exposure (< 1 min) to 0.5 mg/mL hyaluronidase (Sigma Chemical Co., St. Louis, MO, USA), 
adjusted with m-TALP (pH 7.4), a modified Tyrode solution, with, lactate, pyruvate, 0.3% bovine serum albumin 
(Sigma Chemical Co.) and HEPES. Then, oocytes were transferred to m-TALP without hyaluronidase, at 38 °C in 5% 
CO2 until further use. Oocytes were classified by stages as germinal vesicle, metaphase I, metaphase II or degenerate.
Figure 7. Comparison of expression levels of GFP protein from tissues in Tg monkeys and the GFP mice. 
Western blot was performed with 2.5 μ g of proteins extracted from tissues of Tg monkeys, and the GFP mouse 
that carries one copy of the CAG promoter-GFP expression unit. Anti-GFP and β -actin antibodies were used to 
detect GFP and β -actin, respectively. Full-length blots are presented in Supplementary Fig. 3.
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Intracytoplasmic sperm injection. Intracytoplasmic sperm injection was carried out on metaphase 
II-stage oocytes, as previously described59, in m-TALP containing HEPES (mTALP-HEPES). A glass needle 
(Humagen Fertility Diagnostics, Charlottesville, VA, USA), connected to an injector and an inverted microscope 
(Olympus Tokyo, Tokyo, Japan) with a micromanipulator, was used for sperm injection. Intracytoplasmic sperm 
injection was performed with fresh sperm collected by electric stimulation of the penis with no anaesthesia. 
Following ICSI, embryos were cultured in GIBCO CMRL Medium-1066 (Invitrogen, Carlsbad, CA, USA) sup-
plemented with 20% bovine serum (Invitrogen) at 38 °C in 5% CO2 and 5% O2 then blastocyst stage embryos were 
generated in vitro.
Lentiviral vector construction. pCSII-CAG-EGFP was constructed by introducing CAG promoter from 
pCAGGS and GFP cDNA into pCSII-EF-MCS-IRES2-Venus plasmid. pCAGGS was provided by Dr. Hitoshi 
Niwa (Kumamoto Univ.).
Lentiviral vector package and transduction. Viral particles were obtained through Lipofectamine 2000 
(Life Technologies, Calsbad, CA, USA) transfection in 293FT cells, and with packaging plasmids VSVG, RSV-Rev, 
HIVgp plasmids. Viral supernatants were harvested after 48 and 72 h of transfection. The supernatant then was 
clarified by centrifugation (1,000 × g for 5 min at room temperature), passed through a PVDF filter (pore size, 
0.22 μ m), and concentrated by ultracentrifugation (50,000 × g for 2 h at 4 °C). The pellet was suspended in PBS 
and centrifuged on a 20% (w/v) sucrose cushion. After the viral pellet was resuspended in CMRL, the infectious 
unit (IU) was determined by Lenti-X™ p24 Rapid Titer Kit (Takara bio, Shiga, Japan).
Virus injection to embryos. For virus injection to the two-cell-stage embryos, two-cell-stage embryos 
were prepared after 24 h of ICSI and lentivirus was injected into the perivitelline space in 0.25 M sucrose/ 
mTALP-HEPES. For injection to oocytes, metaphase II stage oocytes were selected and lentivirus was injected 
into the perivitelline space in 0.25 M sucrose/ mTALP-HEPES. After 4 h of virus injection, ICSI was performed.
Embryo transfer and pregnancy detection. When embryos developed to expanded blastocysts, one 
or two embryos were transferred into each female recipient. Embryo transfer was performed as previously 
described59, with some modifications. Laparoscopy was carried out on alternate days from days 10–14 of the 
menstrual cycle after menstruation (ovulation day = day 0) until ovulation occurred. Recipients were selected for 
embryo transfer 1–6 day after ovulation. Neither the stage of the embryos nor the number of days after the recipi-
ent’s ovulation were matched. Embryos were aspirated into a catheter (ETC3040SM5-17; Kitazato Medical Service 
Co., Ltd., Tokyo, Japan) under a stereomicroscope. The catheter was inserted into the oviduct of the recipient via 
the fimbria under the laparoscope, and the cultured embryo was transplanted with a small amount of medium. 
Pregnancy was determined by ultrasonography 30 days after ICSI.
RT- quantitative PCR. Total RNA was extracted from cells or tissues using RNeasy Mini kits (Qiagen, 
Hilden, Germany). For reverse transcription, ReverTra Ace (Toyobo Co., Ltd, Osaka, Japan) and oligo (dT) 20 
primer were used. For real-time PCR, THUNDERBIRD SYBR qPCR Mix (Toyobo) was used. Transcript levels 
were determined in triplicate reactions and normalized against the corresponding levels of GAPDH. Primer 
sequences are shown in Supplementary Table 1.
Immunohistochemical analysis. Tissues were fixed by 4% PFA at 4 °C overnight, embedded in OCT 
compound, frozen in liquid nitrogen, sliced into 10-μ m sections and placed onto glass slides that were treated 
with Blocking One for 30 min at room temperature. Primary antibodies and dilutions used were rabbit anti-GFP 
AlexaFluor 488 conjugate (1:400, Life Technologies A21311), mouse anti-Oct4 (1:400, Santa Cruz sc-5279), 
mouse anti-NeuN (1:500, Millipore MAB377), rabbit anti-GFAP (1:500, Biomedical Technologies Inc. BT-575), 
rabbit anti-CD45 (1:100, Dako M0701), rabbit anti-DDX4 (VASA) (1:400, Abcam ab13840), which were then 
detected with appropriate secondary AlexaFluor 488, 568 or 647 antibodies. Cells were counterstained with 
Hoechst 33342 and observed using a Leica TCS SP8 confocal microscope.
FACS analysis. Tail fibroblasts were established from day 92 foetuses (#1 and #2) and day 3 offspring (PreI 
Tg #2). After removal of tail skin, the remaining tails were washed in PBS and maintained in Dulbecco’s mod-
ified eagle medium (DMEM, Invitrogen) containing 10% foetal bovine serum (FBS, JRH Biosciences, Corston 
Bath, UK), penicillin, streptomycin (Invitrogen), and primocin (Invivogen). Ear fibroblasts were established from 
PreI Tg #2 by cutting ears into 5 mm3 fragments, washing in PBS and then cultured in DMEM containing 10% 
FBS, penicillin, streptomycin, and primocin. The fibroblasts were cultured until confluent and then collected by 
trypsin treatment. Cells were resuspended in a final volume of 500 μ l of PBS/2% FCS and analysed with a Becton 
Dickinson FACSAria cell sorter.
Observation of green fluorescence in transgenic offspring. Images were captured under 470 nm 
excitation light with 520-nm wavelength filters using a Nikon D3300 digital camera. No image intensifying pro-
cedures were applied to any of the images. A 1-day-old and 3-month-old cynomolgus monkeys were used as a 
negative control for PreI Tg #1 and #2 respectively.
Western blot analysis. One mm2 of tissues were incubated in RIPA buffer (50 mM Tris-HCl, 150 mM NaCl, 
0.5% sodium deoxycholate, 1% NP40 and 0.1% SDS) with protease and phosphatase inhibitors for 10 min at 
4 °C. After centrifugation (15,000 × g for 5 min), protein samples were obtained from supernatant. Samples were 
diluted in sample buffer (Wako, Osaka, Japan) at a final concentration (10 μ g/μ l) and stored at − 20 °C just before 
assessment. After denaturing by boiling at 95 °C for 5 min, 2.5 μ l of sample was separated by SDS-PAGE on 10% 
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polyacrylamide gel at 250 V for 80 min and then transferred onto a polyvinylidene fluoride membrane (Merck 
Millipore, Darmstadt, Germany). The membrane was blocked using Blocking One, and then incubated with 
rabbit anti-GFP AlexaFluor 488 conjugate (1:2,000) or rabbit anti-β -actin horseradish peroxidase (HRP) con-
jugate (1:4,000) antibody overnight at 4 °C in Blocking One. After three washes in Tween20-PBS (T-PBS), the 
membrane incubated with rabbit anti-GFP was treated with HRP-labeled anti-rabbit immunoglobulin G (1:2,000; 
Invitrogen) in Blocking One for 1 h at room temperature. After one wash of 15 min and five washes of 5 min each 
with T-PBS, peroxidase activity was visualized using the Chemi-Lumi One Super (Nacalai Tesque) according 
to the manufacturer’s instructions. Tissues from a GFP mouse (C57BL/6-Tg(CAG-EGFP)10sb/J)42 that carries 
one copy of the CAG promoter-GFP expression unit were provided by Drs. H. Kojima and M. Katagi (Shiga 
University of Medical Science) and used as a positive control.
Statistical analysis. Statistical analyses of all data comparisons were carried out using the t-test using Excel 
software. P < 0.05 was considered statistically significant.
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